Sun Pharmaceutical Industries (Sun Pharma)is reportedly recalling over ten lakh boxes of its anti-allergic Loratadine drug from the US market as the lot was found to be ‘super potent’ and ‘out of specification’. Such recalls are done by drug makers if there is a defect in the product, which, if unaddressed, could result in stricter action from regulators. The recalled drugs were manufactured and distributed in the US by Ohm Laboratories, a New Jersey-based subsidiary of Ranbaxy.
Sun Pharma is the world’s fifth largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business, economies of scale and an extremely skilled team enable us to deliver quality products in a timely manner at affordable prices. It provides high-quality, affordable medicines trusted by customers and patients in over 150 countries across the world.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1625.75 |
| Dr. Reddys Lab | 1317.60 |
| Cipla | 1284.90 |
| Zydus Lifesciences | 929.85 |
| Lupin | 2297.60 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: